 Desvenlafaxine succinate DVS is a potent and selective serotonin and norepinephrine reuptake inhibitor SNRI. This study will investigate the safety, efficacy, and tolerability of DVS SR versus escitalopram in women with major depressive disorder MDD who are postmenopausal. 